Effects of nonpharmacologic therapy with cardiac rehabilitation and exercise training in patients with low levels of high-density lipoprotein cholesterol

American Journal of Cardiology

Volumn 78, Issue 11, 1996, Pages 1286-1289

  Lavie, Carl J ^a,b   Milani, Richard V ^a  

^a Vascular Institute   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIET THERAPY; HUMAN; HYPERTRIGLYCERIDEMIA; KINESIOTHERAPY; MULTIVARIATE ANALYSIS; RISK FACTOR;

ANALYSIS OF VARIANCE; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; EXERCISE THERAPY; HUMANS; HYPERTRIGLYCERIDEMIA; MULTIVARIATE ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 0030329896     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00614-5     Document Type: Article

References (20)

1. Lavie CJ, Milani RV. National Cholesterol Education Program's recommendations and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs. Am J Cardiol 1991;68:1087-1088.
2. Lavie CJ, O'Keefe JH, Blonde L, Gau GT. High-density lipoprotein cholesterol: recommendations for routine testing and treatment. Postgrad Med 1990;87:36-51.
3. Manninen V, Elo MO, Prick MH, Haapa K, Hernonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitanomi P, Koskinen P, Maenpaa H, Malkonen M, Manttair M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoablom T, Nikkila EA. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641-651.
4. Brown G, Alberts JJ, Fisher LD, Schaefer SM, Lin J-T, Kaplan C, Zhao X-Q, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-1298.
5. Lavie CJ. Lipid and lipoprotein fractions and coronary artery disease. Mayo Clin Proc 1993;68:618-619.
6. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
7. Milani RV, Lavie, CJ. Prevalence and effects of nonpharmacologic treatment of "isolated" low-HDL cholesterol in patients with coronary artery disease. J Cardiopulmonary Rehabil 1995;15:439-444.
8. Tenkanen L, Pietilä K, Manninen V, Mänttäri M. The triglyceride issue revised. Findings from the Helsinki heart study. Arch Intern Med 1994;154:2714-2720.
9. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwala S, Kritchevsky S, Jacobs DR, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993;328(17):1220-1224.
10. Arnon R, Sehayek E, Eisenberg S. Disparate effects of a triglyceride lowering diet and of bezafibrate on the HDL system: a study in patients with hypertriglyceridaemia and low HDL-cholesterol levels. Eur J Clin Invest 1993;23(8):492-498.
11. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol 1994;74:1192-1195.
12. Lavie CJ, Gau GT, Squires RW, Kottke BA. Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin Proc 1988;63:605-621.
13. Lavie CJ, Milani RV. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training. Arch Intern Med 1993;153:982-988.
14. Lavie CJ, Milani RV, Liftman AB. Benefits of cardiac rehabilitation and exercise training in secondary coronary prevention in the elderly. J Am Coll Cardiol 1993;22:678-683.
15. Lavie CJ, Milani RV. Do patients with high baseline exercise capacity benefit from cardiac rehabilitation and exercise programs? Am Heart J 1994;128(No. 6, pt 1):1105-1109.
16. Lavie CJ, Milani RV. Effects of cardiac rehabilitation and exercise training on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in women. Am J Cardiol 1995;75:340-343.
17. Lavie CJ, Milani RV. Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol 1995;76:177-179.
18. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription, 3rd ed.. Philadelphia: Lea & Febiger, 1986:157-172.
19. Lavie CJ, Mailander L, Milani RV. Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease. Am J Cardiol 1992;69:1083-1085.
20. Vega GL, Grundy SM. Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia. Arch Intern Med 1994;154:73-82.